These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36257368)

  • 1. Targeting inhibition of microtubule affinity regulating kinase 4 by Harmaline: Strategy to combat Alzheimer's disease.
    Adnan M; Anwar S; DasGupta D; Patel M; Elasbali AM; Alhassan HH; Shafie A; Siddiqui AJ; Bardakci F; Snoussi M; Hassan MI
    Int J Biol Macromol; 2023 Jan; 224():188-195. PubMed ID: 36257368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Microtubule Affinity Regulating Kinase 4 by Metformin: Exploring the Neuroprotective Potential of Antidiabetic Drug through Spectroscopic and Computational Approaches.
    Ashraf GM; DasGupta D; Alam MZ; Baeesa SS; Alghamdi BS; Anwar F; Alqurashi TMA; Sharaf SE; Al Abdulmonem W; Alyousef MA; Alhumaydhi FA; Shamsi A
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of microtubule affinity regulating kinase 4 by an acetylcholinesterase inhibitor, Huperzine A: Computational and experimental approaches.
    Alrouji M; DasGupta D; Ashraf GM; Bilgrami AL; Alhumaydhi FA; Al Abdulmonem W; Shahwan M; Alsayari A; Atiya A; Shamsi A
    Int J Biol Macromol; 2023 Apr; 235():123831. PubMed ID: 36870649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating MARK4 inhibitory potential of Bacopaside II: Targeting Alzheimer's disease.
    Anwar S; Mohammad T; Azhar MK; Fatima H; Alam A; Hasan GM; Islam A; Kaur P; Hassan MI
    Int J Biol Macromol; 2023 Aug; 245():125364. PubMed ID: 37315665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing memantine in Alzheimer's disease therapy through inhibition of microtubule affinity-regulating kinase: Mechanistic insights.
    Anwar S; Choudhury A; Hussain A; AlAjmi MF; Hassan MI; Islam A
    Int J Biol Macromol; 2024 Mar; 262(Pt 2):130090. PubMed ID: 38342269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based investigation of MARK4 inhibitory potential of Naringenin for therapeutic management of cancer and neurodegenerative diseases.
    Anwar S; Khan S; Shamsi A; Anjum F; Shafie A; Islam A; Ahmad F; Hassan MI
    J Cell Biochem; 2021 Oct; 122(10):1445-1459. PubMed ID: 34121218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of pyrazolopyrimidine derivatives as microtubule affinity regulating kinase 4 inhibitors: Towards therapeutic management of Alzheimer's disease.
    Naqvi AAT; Jairajpuri DS; Noman OMA; Hussain A; Islam A; Ahmad F; Alajmi MF; Hassan MI
    J Biomol Struct Dyn; 2020 Aug; 38(13):3892-3907. PubMed ID: 31512980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAP/Microtubule Affinity Regulating Kinase 4 Inhibitory Potential of Irisin: A New Therapeutic Strategy to Combat Cancer and Alzheimer's Disease.
    Waseem R; Anwar S; Khan S; Shamsi A; Hassan MI; Anjum F; Shafie A; Islam A; Yadav DK
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and biochemical investigation of MARK4 inhibitory potential of cholic acid: Towards therapeutic implications in neurodegenerative diseases.
    Anwar S; Shamsi A; Kar RK; Queen A; Islam A; Ahmad F; Hassan MI
    Int J Biol Macromol; 2020 Oct; 161():596-604. PubMed ID: 32535203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic insights into MARK4 inhibition by galantamine toward therapeutic targeting of Alzheimer's disease.
    Adnan M; DasGupta D; Anwar S; Shamsi A; Siddiqui AJ; Snoussi M; Bardakci F; Patel M; Hassan MI
    Front Pharmacol; 2023; 14():1276179. PubMed ID: 37795023
    [No Abstract]   [Full Text] [Related]  

  • 11. MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer's Disease Therapy.
    Shamsi A; Anwar S; Mohammad T; Alajmi MF; Hussain A; Rehman MT; Hasan GM; Islam A; Hassan MI
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32443670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PKR-inhibitor binds efficiently with human microtubule affinity-regulating kinase 4.
    Naz F; Shahbaaz M; Khan S; Bisetty K; Islam A; Ahmad F; Hassan MI
    J Mol Graph Model; 2015 Nov; 62():245-252. PubMed ID: 26519933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosmarinic Acid Exhibits Anticancer Effects via MARK4 Inhibition.
    Anwar S; Shamsi A; Shahbaaz M; Queen A; Khan P; Hasan GM; Islam A; Alajmi MF; Hussain A; Ahmad F; Hassan MI
    Sci Rep; 2020 Jun; 10(1):10300. PubMed ID: 32587267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing New Kinase Inhibitor Derivatives as Therapeutics Against Common Complex Diseases: Structural Basis of Microtubule Affinity-Regulating Kinase 4 (MARK4) Inhibition.
    Naz F; Shahbaaz M; Bisetty K; Islam A; Ahmad F; Hassan MI
    OMICS; 2015 Nov; 19(11):700-11. PubMed ID: 26565604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of human microtubule affinity-regulating kinase 4 inhibitors: fluorescence binding studies, enzyme, and cell assays.
    Naz F; Sami N; Naqvi AT; Islam A; Ahmad F; Imtaiyaz Hassan M
    J Biomol Struct Dyn; 2017 Nov; 35(14):3194-3203. PubMed ID: 27748164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4).
    Mohammad T; Khan FI; Lobb KA; Islam A; Ahmad F; Hassan MI
    J Biomol Struct Dyn; 2019 Apr; 37(7):1813-1829. PubMed ID: 29683402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, molecular docking and inhibition studies of novel 3-N-aryl substituted-2-heteroarylchromones targeting microtubule affinity regulating kinase 4 inhibitors.
    Parveen I; Khan P; Ali S; Hassan MI; Ahmed N
    Eur J Med Chem; 2018 Nov; 159():166-177. PubMed ID: 30290280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of MARK4 by serotonin as an attractive therapeutic approach to combat Alzheimer's disease and neuroinflammation.
    Shamsi A; DasGupta D; Alhumaydhi FA; Khan MS; Alsagaby SA; Al Abdulmonem W; Hassan MI; Yadav DK
    RSC Med Chem; 2022 Jun; 13(6):737-745. PubMed ID: 35814926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microtubule affinity-regulating kinase 4 with an Alzheimer's disease-related mutation promotes tau accumulation and exacerbates neurodegeneration.
    Oba T; Saito T; Asada A; Shimizu S; Iijima KM; Ando K
    J Biol Chem; 2020 Dec; 295(50):17138-17147. PubMed ID: 33020179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ropinirole reverses the effects of neuroinflammation, and cellular demise by downregulating the MARK4-NFκβ signaling system in Alzheimer's disease.
    Neha ; Anwar S; Pinky ; Hassan MI; Parvez S
    Int J Biol Macromol; 2024 Jun; 271(Pt 1):132425. PubMed ID: 38759860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.